JP2005529935A5 - - Google Patents

Download PDF

Info

Publication number
JP2005529935A5
JP2005529935A5 JP2004509687A JP2004509687A JP2005529935A5 JP 2005529935 A5 JP2005529935 A5 JP 2005529935A5 JP 2004509687 A JP2004509687 A JP 2004509687A JP 2004509687 A JP2004509687 A JP 2004509687A JP 2005529935 A5 JP2005529935 A5 JP 2005529935A5
Authority
JP
Japan
Prior art keywords
alkyl
branched
linear
group
camptothecin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004509687A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005529935A (ja
JP4593270B2 (ja
Filing date
Publication date
Priority claimed from IT2002RM000306A external-priority patent/ITRM20020306A1/it
Application filed filed Critical
Publication of JP2005529935A publication Critical patent/JP2005529935A/ja
Publication of JP2005529935A5 publication Critical patent/JP2005529935A5/ja
Application granted granted Critical
Publication of JP4593270B2 publication Critical patent/JP4593270B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004509687A 2002-05-31 2003-05-28 カンプトテシンの20位のエステル Expired - Fee Related JP4593270B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000306A ITRM20020306A1 (it) 2002-05-31 2002-05-31 Esteri in posizione 20 di camptotecine.
PCT/IT2003/000329 WO2003101996A2 (en) 2002-05-31 2003-05-28 Esters in position 20 of camptothecins

Publications (3)

Publication Number Publication Date
JP2005529935A JP2005529935A (ja) 2005-10-06
JP2005529935A5 true JP2005529935A5 (enExample) 2006-07-13
JP4593270B2 JP4593270B2 (ja) 2010-12-08

Family

ID=11456339

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004509687A Expired - Fee Related JP4593270B2 (ja) 2002-05-31 2003-05-28 カンプトテシンの20位のエステル

Country Status (21)

Country Link
US (2) US7452900B2 (enExample)
EP (2) EP1509529B1 (enExample)
JP (1) JP4593270B2 (enExample)
KR (1) KR101000963B1 (enExample)
CN (1) CN100376583C (enExample)
AR (1) AR040140A1 (enExample)
AT (1) ATE439362T1 (enExample)
AU (1) AU2003241161C1 (enExample)
CA (1) CA2487252C (enExample)
CY (2) CY1109581T1 (enExample)
DE (1) DE60328777D1 (enExample)
DK (2) DK1509529T3 (enExample)
ES (2) ES2331569T3 (enExample)
IT (1) ITRM20020306A1 (enExample)
MX (1) MXPA04011681A (enExample)
PE (1) PE20040533A1 (enExample)
PL (1) PL374009A1 (enExample)
PT (2) PT1509529E (enExample)
SI (2) SI1509529T1 (enExample)
TW (1) TWI331151B (enExample)
WO (1) WO2003101996A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
CN1946421B (zh) 2004-04-27 2013-07-17 威尔斯达特生物制剂公司 使用病毒和喜树碱进行的癌症治疗
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
RU2435586C2 (ru) 2005-07-14 2011-12-10 Веллстат Байолоджикс Корпорейшн Лечение рака с применением вирусов, фторпиримидинов и камптотецинов
CN103864811A (zh) * 2012-12-13 2014-06-18 天津科技大学 一种新颖的10-羟基喜树碱20位衍生物制备方法及其在抗肿瘤药物中的应用
WO2014121033A1 (en) * 2013-02-04 2014-08-07 Fl Therapeutics Llc Soluble complexes of drug analogs and albumin
WO2015200837A1 (en) 2014-06-27 2015-12-30 Fl Therapeutics Llc Abiraterone derivatives and non-covalent complexes with albumin
WO2016065139A1 (en) 2014-10-24 2016-04-28 Fl Therapeutics Llc 3-substituted piperidine-2, 6-diones and non-covalent complexes with albumin
JP6877049B2 (ja) 2015-09-25 2021-05-26 ゼットワイ セラピューティクス インク.Zy Therapeutics Inc. 多糖類−ビタミン共役体を含む粒状物に基づく薬物製剤
CN106279286B (zh) * 2016-08-12 2018-11-30 华中科技大学 一种喜树碱膦酸酯类化合物、其制备方法及应用
CN110577551A (zh) * 2018-06-08 2019-12-17 遵义医学院 喜树碱-甘氨酸-5,6-二溴去甲斑蝥素结合物及其应用
BR112022000401A2 (pt) 2019-07-11 2022-03-29 Sun Pharma Advanced Res Co Ltd Derivados de camptotecina com uma porção dissulfeto e uma porção piperazina
CN116514829A (zh) * 2020-08-21 2023-08-01 诺茗(北京)生物医药有限公司 一种水溶性抗肿瘤前药及其药物组合物和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JP3186166B2 (ja) * 1992-02-10 2001-07-11 ロンザ リミテッド サリチロイル−カルニチンおよびその製造方法
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
WO1997021865A1 (en) 1995-12-15 1997-06-19 The Dexter Corporation Abrasive nonwoven web and method of manufacture
PT1100589E (pt) 1998-07-30 2005-05-31 Sigma Tau Ind Farmaceuti Utilizacao de propionil-l-carnitina e acetil-l-carnitina na preparacao de medicamentos com actividade anticancerigena
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
PT1044977E (pt) 1999-03-09 2002-09-30 Sigma Tau Ind Farmaceuti Derivados de camptotecina com actividade antitumoral
DE19916945C1 (de) 1999-04-15 2000-10-05 Clariant Gmbh Aromatische Aldehydharze und ihre Verwendung als Emulsionsspalter
US6228855B1 (en) 1999-08-03 2001-05-08 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers
US6288072B1 (en) * 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition
US6629995B1 (en) 2000-03-31 2003-10-07 Super Gen, Inc. Camptothecin conjugates

Similar Documents

Publication Publication Date Title
JP2005529935A5 (enExample)
JP2002539128A5 (enExample)
JP2005502621A5 (enExample)
IL176107A0 (en) Azabicyclic heterocycles as cannabinoid receptor modulators
JP2009524676A5 (enExample)
JP2008526999A5 (enExample)
RU2003115490A (ru) Амидные производные в качестве антагонистов nmda рецептора
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
JP2007145875A5 (enExample)
JP2003509349A5 (enExample)
JP2009504764A5 (enExample)
JP2011526924A5 (enExample)
RU2006105652A (ru) Трициклические ингибиторы парп
MX2010007375A (es) Nuevos derivados de lupano.
MX2010007374A (es) Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos.
JP2005525322A5 (enExample)
JP2011507896A5 (enExample)
JP2011527704A (ja) 経口抗がん製剤
JP2013514980A5 (enExample)
MX2009010165A (es) Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704.
BR0308133A (pt) Forma polimórfica cristalina de cloridrato de irinotecan
JP2012523458A5 (enExample)
EA200900244A1 (ru) Модуляторы активности хемокиновых рецепторов, их кристаллические формы и способ их получения
JP2017525717A5 (enExample)
CA2487252A1 (en) Esters in position 20 of camptothecins